Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 18, Issue 1, Pages 1-2Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41571-020-00441-5
Keywords
-
Categories
Ask authors/readers for more resources
The COVID-19 pandemic has disrupted global healthcare systems, especially affecting patients with cancer who seem to be more susceptible to the disease. There is currently no specific therapy offering survival benefits to this unique patient population, and the long-term effects on routine cancer care are expected to be felt for decades.
The coronavirus disease 2019 (COVID-19) pandemic has disrupted health care worldwide. Patients with cancer seem to be particularly susceptible to morbidities and mortality from this novel disease. No COVID-19-specific therapy currently seems to offer a survival benefit to this unique patient population. Furthermore, the global effects on routine cancer care will likely be felt for decades to come.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available